Sridhar J, Akula N, Pattabiraman N: Selectivity and potency of cyclin-dependent kinase inhibitors. In: AAPS J. 8. Jahrgang, Nr.1, 2006, S.E204–21, doi:10.1208/aapsj080125, PMID 16584130, PMC 2751441 (freier Volltext).
Chung CT, Santos Gda C, Hwang DM, et al.: FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma. In: J. Clin. Pathol. 63. Jahrgang, Nr.7, Juli 2010, S.630–4, doi:10.1136/jcp.2010.076794, PMID 20591913.
Sridhar J, Akula N, Pattabiraman N: Selectivity and potency of cyclin-dependent kinase inhibitors. In: AAPS J. 8. Jahrgang, Nr.1, 2006, S.E204–21, doi:10.1208/aapsj080125, PMID 16584130, PMC 2751441 (freier Volltext).
Chung CT, Santos Gda C, Hwang DM, et al.: FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma. In: J. Clin. Pathol. 63. Jahrgang, Nr.7, Juli 2010, S.630–4, doi:10.1136/jcp.2010.076794, PMID 20591913.
Kordi-Tamandani DM, Moazeni-Roodi A, Rigi Ladez MA, Hashemi M, Birjandian E, Torkamanzehi A: Analysis of methylation patterns and expression profiles of p14ARF gene in patients with oral squamous cell carcinoma. In: Int. J. Biol. Markers. 25. Jahrgang, Nr.2, 2010, S.99–103, PMID 20586029.
Ayhan S, Isisag A, Saruc M, Nese N, Demir MA, Kucukmetin NT: The role of pRB, p16 and cyclin D1 in colonic carcinogenesis. In: Hepatogastroenterology. 57. Jahrgang, Nr.98, 2010, S.251–6, PMID 20583423.